Evidence map›Paper›PMID 34172715›Full record

ArticleCell death & disease2021

Parp mutations protect from mitochondrial toxicity in Alzheimer's disease.

Yizhou Yu, Giorgio Fedele, Ivana Celardo, Samantha H Y Loh, L Miguel Martins

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 41 citations in OpenAlex.

  1. Heat-treatedJournal of microbiology and biotechnology · 2026
    Trial
  2. Article
  3. PARP1 deficiency mitigates amyloid pathology, neurodegeneration, and cognitive decline in a familial Alzheimer's disease model.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. NADAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  5. Review
  6. International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Autophagy-NADFrontiers in molecular biosciences · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Mitochondrial One-Carbon Metabolism and Alzheimer's Disease.International journal of molecular sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yizhou YuMRC Toxicology Unit, University of Cambridge, Cambridge, UK.
Giorgio FedeleMRC Toxicology Unit, University of Cambridge, Cambridge, UK.ORCID 0000-0002-9878-0070
Ivana CelardoMRC Toxicology Unit, University of Cambridge, Cambridge, UK.
Samantha H Y LohMRC Toxicology Unit, University of Cambridge, Cambridge, UK. shyl2@mrc-tox.cam.ac.uk.
L Miguel MartinsMRC Toxicology Unit, University of Cambridge, Cambridge, UK. martins.lmiguel@gmail.com.ORCID 0000-0002-3019-4809
University of Cambridge · GB

Funding

Medical Research Council MC_U132674518Medical Research Council MC_UU_00025/3RCUK | Medical Research Council (MRC) MC_UU_00025/3 (RG94521)
6 · The paper itself

Abstract

Alzheimer's disease is the most common age-related neurodegenerative disorder. Familial forms of Alzheimer's disease associated with the accumulation of a toxic form of amyloid-β (Aβ) peptides are linked to mitochondrial impairment. The coenzyme nicotinamide adenine dinucleotide (NAD

Indexed as

MutationAlzheimer DiseaseAmyloid beta-PeptidesAnimalsAnimals, Genetically ModifiedBehavior, AnimalDisease Models, AnimalDrosophila melanogasterDrosophila ProteinsHumansMetabolomeMetabolomicsMitochondriaMotor ActivityNADNerve DegenerationAmyloid beta-PeptidesDrosophila ProteinsNADNiacinamidePARP1 protein, humanParp protein, DrosophilaPoly (ADP-Ribose) Polymerase-1

Identifiers

PMID34172715
PMCPMC8233423
OpenAlexW3174624813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.